European Urology Open Science (Jul 2020)
Results of a phase II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin (BCG) VPM1002BC in patients with BCG failure - SAKK 06/14
- C.A. Rentsch,
- G. Thalmann,
- I. Lucca,
- M. Kwiatkowski,
- G. Wirth,
- R. Strebel,
- D. Engeler,
- A. Pedrazzini,
- C. Hüttenbrink,
- W. Schultze-Seemann,
- L. Bubendorf,
- A. Wicki,
- B. Roth,
- P. Bosshard,
- H. Püschel,
- D. Boll,
- L. Hefermehl,
- F. Roghmann,
- M. Gierth,
- S. Schäfer,
- S. Hayoz
Affiliations
- C.A. Rentsch
- G. Thalmann
- I. Lucca
- M. Kwiatkowski
- G. Wirth
- R. Strebel
- D. Engeler
- A. Pedrazzini
- C. Hüttenbrink
- W. Schultze-Seemann
- L. Bubendorf
- A. Wicki
- B. Roth
- P. Bosshard
- H. Püschel
- D. Boll
- L. Hefermehl
- F. Roghmann
- M. Gierth
- S. Schäfer
- S. Hayoz
- Journal volume & issue
-
Vol. 19
pp. e1183 – e1184